Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaxone for inflammatory heart failure exacerbation
MOH_2021-05-10_009957Phase 2Completed
- Sponsor
- פרופ עופר אמיר
- Start
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of glatiramer acetate in heart failure (HF) (2 arms), sponsored by פרופ עופר אמיר. Started Jan 2021; status: completed.
02
Drugs
glatiramer acetate
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on MOH_2021-05-10_009957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-05-10_009957.